Literature DB >> 7529826

Antagonist and partial agonist actions of d-tubocurarine at mammalian muscle acetylcholine receptors.

J H Steinbach1, Q Chen.   

Abstract

Currents were elicited by acetylcholine (ACh), by d-tubocurarine (dTC), and by mixtures of ACh and dTC, from stably transformed fibroblasts that express fetal or adult muscle nicotinic receptors. dTC acted as an antagonist of ACh for activation of adult-type receptors, whereas it acted as a weak partial agonist at fetal-type receptors. The channel-blocking action of dTC was not apparent at the concentrations used. The partial agonism could explain previous observations that dTC is less effective at blocking the responses of fetal-type receptors than adult-type receptors. Binding of dTC to receptors was independently assayed by measuring the reduction of the initial rate of binding of iodinated alpha-bungarotoxin. Binding of dTC to the two types of receptor was indistinguishable. The dose-effect relationship for the interaction of dTC and ACh at fetal receptors is consistent with the affinities of dTC measured in binding experiments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529826      PMCID: PMC6578313     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  10 in total

1.  Neonatal partial denervation results in nodal but not terminal sprouting and a decrease in efficacy of remaining neuromuscular junctions in rat soleus muscle.

Authors:  J L Lubischer; W J Thompson
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

2.  Potency of nondepolarizing muscle relaxants on muscle-type acetylcholine receptors in denervated mouse skeletal muscle.

Authors:  Hong WANG; Bin YANG; Guang-wei HAN; Shi-tong LI
Journal:  Acta Pharmacol Sin       Date:  2010-11-22       Impact factor: 6.150

3.  Activation of heteroliganded mouse muscle nicotinic receptors.

Authors:  Gustav Akk; Lorin S Milescu; Manfred Heckmann
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

4.  Regulation of nicotinic receptor expression by the ubiquitin-proteasome system.

Authors:  John C Christianson; William N Green
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

5.  The kinetics of competitive antagonism of nicotinic acetylcholine receptors at physiological temperature.

Authors:  Deeptankar Demazumder; James P Dilger
Journal:  J Physiol       Date:  2007-12-06       Impact factor: 5.182

Review 6.  Oxidative Cyclization in Natural Product Biosynthesis.

Authors:  Man-Cheng Tang; Yi Zou; Kenji Watanabe; Christopher T Walsh; Yi Tang
Journal:  Chem Rev       Date:  2016-12-12       Impact factor: 60.622

7.  Riluzole blocks human muscle acetylcholine receptors.

Authors:  Cristina Deflorio; Eleonora Palma; Luca Conti; Cristina Roseti; Alessia Manteca; Elena Giacomelli; Myriam Catalano; Cristina Limatola; Maurizio Inghilleri; Francesca Grassi
Journal:  J Physiol       Date:  2012-03-19       Impact factor: 5.182

8.  Activation and modulation of human α4β2 nicotinic acetylcholine receptors by the neonicotinoids clothianidin and imidacloprid.

Authors:  Ping Li; Jason Ann; Gustav Akk
Journal:  J Neurosci Res       Date:  2011-04-28       Impact factor: 4.164

9.  Potency of agonists and competitive antagonists on adult- and fetal-type nicotinic acetylcholine receptors.

Authors:  C S Yost; B D Winegar
Journal:  Cell Mol Neurobiol       Date:  1997-02       Impact factor: 5.046

10.  Structural mechanism of muscle nicotinic receptor desensitization and block by curare.

Authors:  Md Mahfuzur Rahman; Tamara Basta; Jinfeng Teng; Myeongseon Lee; Brady T Worrell; Michael H B Stowell; Ryan E Hibbs
Journal:  Nat Struct Mol Biol       Date:  2022-03-17       Impact factor: 18.361

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.